Shire settles with Teva over ADHD drug

04-06-2013

Drug-maker Teva must wait until 2015 before selling generic versions of Shire’s Intuniv product, according to a patent settlement between the companies.


shire, teva, intuniv, adhd, actavis

LSIPR